Aethlon Medical announces undetectable Ebola Virus in patient treated with Hemopurifier therapy
Patient suffering from multiple organ failure recovering from ebola infection Aethlon Medical, Inc. (OTCBB:AEMD), the pioneer in…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Pfizer posts Rs 269 crores revenue in quarter ended September 30, 2014
Profit from operation for the quarter is Rs 48 crores
Govt bracing up to popularise traditional medicines
Healers from the south, west, central and Northeast India at the meet expressed anguish that traditional treatment systems in…
FDA committee votes against Novartis’ multiple myeloma lead
FDA not bound to follow Committee's guidance its review of LBH589 NDA
India to have exclusive drug control department for Ayurveda
Health Minister inaugurates Arogya Expo at the 6th WAC
GVK BIO signs definitive agreement to acquire Vanta Bioscience
The acquisition enables GVK BIO to offer GLP toxicology services for pharmaceuticals, agrochemicals, nutraceuticals, and cosmetics…
Life Sciences students trained by Biocon Academy ready to join industry
The third batch of the Biocon Academy commenced on 3rd Nov’ at Bangalore
India to have exclusive drug control department for Ayurveda
Health Minister inaugurates Arogya Expo at the 6th WAC
GVK BIO signs definitive agreement to acquire Vanta Bioscience
The acquisition enables GVK BIO to offer GLP toxicology services for pharmaceuticals, agrochemicals, nutraceuticals, and cosmetics…
Life Sciences students trained by Biocon Academy ready to join industry
The third batch of the Biocon Academy commenced on 3rd Nov’ at Bangalore
Glenmark enrols first patient for phase II trial of GBR 500
The company out licensed Vatelizumab (GBR 500) to Sanofi for all indications in 2011
Ranbaxy Laboratories obtains US FDA approval to market fenofibrate capsules
Fenofibrate capsules are indicated for primary hypercholesterolemia and mixed dyslipidemia. In addition, it is indicated for…
Glenmark Generics receives final ANDA approval for Omeprazole DR capsules
It is a generic version of Prilosec by AstraZeneca
Glenmark enrols first patient for phase II trial of GBR 500
The company out licensed Vatelizumab (GBR 500) to Sanofi for all indications in 2011
Ranbaxy obtains US FDA approval to market fenofibrate capsules
Fenofibrate capsules are indicated for primary hypercholesterolemia and mixed dyslipidemia. In addition, it is indicated for…
Glenmark Generics receives final ANDA approval for Omeprazole DR capsules
It is a generic version of Prilosec by AstraZeneca
Study confirms positive safety profile and effectiveness of Pradaxa in atrial fibrillation patients
The US FDA Medicare study of 134,000 patients demonstrates benefits such as a significantly reduced risk of ischaemic stroke, a…
Phase III efficacy clinical study results of Sanofi’s Dengue vaccine candidate published
Study successfully met primary objective and confirms high efficacy against severe dengue and hospitalisation
Study confirms positive safety profile and effectiveness of Pradaxa in atrial fibrillation patients
The US FDA Medicare study of 134,000 patients demonstrates benefits such as a significantly reduced risk of ischaemic stroke, a…
Multisorb Technologies appoints Peter Lirusso to Healthcare Packaging Group for Canada
Lirusso brings vast experience in films, foils, and ridged plastics and blister packs within the pharmaceutical industry. And…